Funds and ETFs Alliance Pharma plc

Equities

APH

GB0031030819

Pharmaceuticals

Market Closed - London S.E. 11:35:09 2024-04-26 am EDT 5-day change 1st Jan Change
34.95 GBX +0.14% Intraday chart for Alliance Pharma plc -5.16% -13.70%
Alliance Pharma plc is a United Kingdom-based consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's segments are strategic business units that represent different parts of the overall product portfolio, these being Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are sold around the world in more than 100 countries.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.3495 GBP
Average target price
0.6743 GBP
Spread / Average Target
+92.93%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. APH Stock
  4. Funds and ETFs Alliance Pharma plc